VRTX FY 2020 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$125B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6.2B+49.1% YoY

Gross Profit

$5.5B88.1% margin

Operating Income

$2.9B46.0% margin

Net Income

$2.7B43.7% margin

EPS (Diluted)

$10.29

Cash Flow

Operating Cash Flow

$3.3B

Free Cash Flow

$3.0B

Stock-Based Comp.

$430M

Balance Sheet

Total Assets

$11.8B

Total Liabilities

$3.1B

Stockholders' Equity

$8.7B

Cash & Equivalents

$6.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6.2B	$4.2B	+49.1%
Gross Profit	$5.5B	$3.6B	+51.3%
Operating Income	$2.9B	$1.2B	+138.5%
Net Income	$2.7B	$1.2B	+130.4%